May 2022- The official launch of InfiniSEEKTM, an innovative, economical solution for whole genome sequencing and targeted SNP analysis, was announced by Neogen® Corporation and Gencove, the industry-leading low-pass whole genome sequencing and analysis software firm.
June 2022- Basepaws is a privately held petcare genetics firm that offers pet owners genetic tests, analytics, and early health risk assessments. Zoetis Inc. announced the completion of its acquisition of Basepaws. A pet's risk for the disease can be better understood by pet owners and doctors with the help of genetic insights from Basepaws. This can result in more meaningful interactions and improve the chances of early disease identification and treatment. The acquisition was first disclosed on June 7th, but the financial details of the deal were not made public.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4390
Published Date: Oct 31, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increased investments in R&D, the emergence of precision livestock farming, and changing consumer preferences are some of the market growth factors.
The market size of animal genetics is anticipated to attain a CAGR of 17% over the forecast period, i.e., 2024-2036.
The major players in the market are Genus plc, Animal Genetics, Inc., Neogen Corporation, TOPIGS NORSVIN, Zoetis Services LLC, GROUPE GRIMAUD LA, ANICAM ENTERPRISES INC, Trans Ova Genetics., GenEra, HOKKO CHEMICAL INDUSTRY CO., LTD. And others
The embryo segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.